Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer

NCT02549989 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer
Recurrent Endometrial Cancer

Interventions

DRUG: LY3023414

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]